Immunology, Pathology, Immune system, Cytotoxic T cell and Cytokine are his primary areas of study. His Immunology research includes themes of Disease and Lymph. In Pathology, Steven W. Dow works on issues like Stem cell, which are connected to Adipose tissue, Inflammatory bowel disease and Bioinformatics.
His Immune system study integrates concerns from other disciplines, such as Spleen and Cytotoxicity. In his research on the topic of Cytokine, Cationic liposome and Cancer research is strongly related with Gene delivery. His work in CD8 addresses subjects such as T cell, which are connected to disciplines such as Adjuvant, Immunization, Liposome and Pharmacology.
His scientific interests lie mostly in Immunology, Immune system, Internal medicine, Microbiology and Mesenchymal stem cell. Immunology is a component of his Immunotherapy, Immunity, Antibody, CD8 and Vaccination studies. His work deals with themes such as Infectious disease, Disease and Antigen, which intersect with Immune system.
His Internal medicine research incorporates themes from Gastroenterology and Endocrinology. His study on Microbiology also encompasses disciplines like
Steven W. Dow mostly deals with Mesenchymal stem cell, Immune system, Immunology, In vitro and Antibiotics. The Mesenchymal stem cell study combines topics in areas such as Viability assay, Anesthesia and Elbow. His Innate immune system and CCR2 study in the realm of Immune system connects with subjects such as Bull Terrier.
Immunity, Inflammation and Antibody are subfields of Immunology in which his conducts study. His studies in In vitro integrate themes in fields like Cancer research, Cytokine, Dexamethasone, Microbiology and Stem cell. The various areas that Steven W. Dow examines in his Antibiotics study include Respiratory tract, Antimicrobial, Respiratory tract infections and In vivo.
Steven W. Dow mainly focuses on Mesenchymal stem cell, Immune system, In vitro, Innate immune system and Synovial fluid. His Mesenchymal stem cell study combines topics in areas such as Surgery and Lameness. His Immune system research is within the category of Immunology.
While the research belongs to areas of Immunology, Steven W. Dow spends his time largely on the problem of Microbiome, intersecting his research to questions surrounding Immunotherapy. His In vitro research incorporates themes from Neutrophil extracellular traps, Biofilm, Wound healing, Microbiology and Stem cell. His Anesthesia study combines topics in areas such as Adverse effect and Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously.
Steven W. Dow;Lee G. Fradkin;Denny H. Liggitt;Andy P. Willson.
Journal of Immunology (1999)
Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes.
Karen Zaks;Michael Jordan;Amanda Guth;Karen Sellins.
Journal of Immunology (2006)
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns.
D L Sodora;E G Shpaer;B E Kitchell;S W Dow.
Journal of Virology (1994)
Lung environment determines unique phenotype of alveolar macrophages
Amanda Michele Guth;William J. Janssen;Catherine M. Bosio;Erika C. Crouch.
American Journal of Physiology-lung Cellular and Molecular Physiology (2009)
Feline immunodeficiency virus: a neurotropic lentivirus.
Steven W. Dow;Mary L. Poss;Edward A. Hoover.
Journal of Acquired Immune Deficiency Syndromes (1990)
Francisella tularensis Induces Aberrant Activation of Pulmonary Dendritic Cells
Catharine M. Bosio;Steven W. Dow.
Journal of Immunology (2005)
Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation.
Genevieve P Hartley;Lyndah Chow;Dylan T Ammons;William H Wheat.
Cancer immunology research (2018)
Dietary Selenium Modulates Activation and Differentiation of CD4+ T Cells in Mice through a Mechanism Involving Cellular Free Thiols
FuKun W. Hoffmann;Ann C. Hashimoto;Leigh Anne Shafer;Steven Dow.
Journal of Nutrition (2010)
Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer
B.J. Biller;R.E. Elmslie;R.C. Burnett;A.C. Avery.
Veterinary Immunology and Immunopathology (2007)
Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
Susan Lana;Lance U'ren;Susan Plaza;Robyn Elmslie.
Journal of Veterinary Internal Medicine (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: